76 results
Page 2 of 4
6-K
EX-99.1
ksi grr2oe4
23 Jun 22
First Quarter Interim Statement JANUARY – MARCH
6:30am
6-K
EX-99.1
j5b7h759
14 Jun 22
MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210
4:08pm
6-K
EX-99.1
0i8xl1nw0tl uak
23 Mar 22
Current report (foreign)
4:15pm
6-K
EX-99.1
6kxqlmbwhik nwhg1
16 Mar 22
Current report (foreign)
5:13pm
6-K
EX-99.1
712yngkzmvqh846yat
16 Mar 22
2021 Annual Report A nn ua l R ep or t 20 21
4:55pm
6-K
EX-99.1
z9bvowlh2jdiij
25 Jan 22
MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards’ Gender Equality Index Report
7:16am
6-K
035hzae
25 Jan 22
MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards’ Gender Equality Index Report
7:16am
6-K
EX-99.1
8d04x
10 Nov 21
MorphoSys Announces Departure of Roland Wandeler
6:14am
SC TO-T
EX-99
eyab354kyn7jhubbsr5
16 Jun 21
Third party tender offer statement
4:52pm
6-K/A
EX-99.1
tvtqqqj
7 May 21
First Quarter Interim Statement
11:58am
6-K
EX-99.1
187a4bwxdv0
5 May 21
First Quarter Interim Statement
4:21pm
6-K
EX-99.1
a860r7cw su2prb
23 Mar 21
Current report (foreign)
3:53pm
6-K
EX-99.1
5daohk3ty
22 Mar 21
Current report (foreign)
12:42pm
6-K
EX-99.1
uvx6lzgjsk n7sj
7 Jan 21
MorphoSys Appoints Sung Lee as Chief Financial Officer
6:14am
6-K
EX-99.1
j34l48joez344s3t
2 Dec 20
Thomas Biegi Joins MorphoSys as Head of Corporate Communications
8:37am
6-K
EX-99.2
fiz0ame2hrm33p
12 Nov 20
MorphoSys Reports Nine Months and Third Quarter
4:48pm
6-K
EX-99.1
qngx3
30 Sep 20
Current report (foreign)
11:00am
6-K
EX-99.1
z1pxd
18 Sep 20
MorphoSys and Incyte to Host Investor Event to Discuss the Unmet
8:12am